279
Views
32
CrossRef citations to date
0
Altmetric
Research Article

L-ascorbic acid and α-tocopherol attenuate arsenic trioxide-induced toxicity in H9c2 cardiomyocytes by the activation of Nrf2 and Bcl2 transcription factors

, , &
Pages 353-360 | Received 29 Jun 2017, Accepted 24 Dec 2017, Published online: 18 Jan 2018

References

  • Aravind L, Dixit VM, Koonin EV. 2001. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science. 291:1279–1284.
  • Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S, Pakay JL, Parker N. 2004. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med. 37:755–767.
  • Christen WG, Gaziano JM, Hennekens CH. 2000. Design of Physicians' Health Study II—a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol. 10:125–134.
  • Danial NN, Korsmeyer SJ. 2004. Cell death: critical control points. Cell. 116:205–219.
  • Ermak G, Davies KJ. 2002. Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol. 38:713–721.
  • Ficker E, Kuryshev YA, Dennis AT, Obejero-Paz C, Wang L, Hawryluk P, Wible BA, Brown AM. 2004. Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol. 66:33–44.
  • Flora SJ. 2009. Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure. Oxid Med Cell Longev. 2:191–206.
  • Frenkel K, Gleichauf C. 1991. Hydrogen peroxide formation by cells treated with a tumor promoter. Free Radic Res Commun. 13:783–794.
  • Garcia-Closas R, Berenguer A, José Tormo M, José Sánchez M, Quirós JR, Navarro C, Arnaud R, Dorronsoro M, Dolores Chirlaque M, Barricarte A, et al. 2004. Dietary sources of vitamin C, vitamin E and specific carotenoids in Spain. Br J Nutr. 91:1005–1011.
  • Gousul Azam SMG, Afrin S, Naz S. 2017. Arsenic in cereals, their relation with human health risk, and possible mitigation strategies. Food Rev Int. 33:620–643.
  • Halestrap AP, Pasdois P. 2009. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta. 1787:1402–1415.
  • Higgins LG, Kelleher MO, Eggleston IM, Itoh K, Yamamoto M, Hayes JD. 2009. Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicol Appl Pharmacol. 237:267–280.
  • Huigsloot M, Tijdens IB, Mulder GJ, van de Water B. 2002. Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells. J Biol Chem. 277:35869–35879.
  • Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M. 2000. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem. 275:16023–16029.
  • Kalender S, Kalender Y, Ogutcu A, Uzunhisarcikli M, Durak D, Açikgoz F. 2004. Endosulfan-induced cardiotoxicity and free radical metabolism in rats: the protective effect of vitamin E. Toxicology. 202:227–235.
  • Kirkinezos IG, Moraes CT. 2001. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol. 12: 449–457.
  • Low ICC, Chen ZX, Pervaiz S. 2010. Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. Antioxid Redox Signal. 13:807–819.
  • Lutsenko EA, Carcamo JM, Golde DW. 2002. Vitamin C prevents DNA mutation induced by oxidative stress. J Biol Chem. 277:16895–16899.
  • Mandal BK, Suzuki KT. 2002. Arsenic round the world: a review. Talanta. 58:201–235.
  • Maritim AC, Sanders A, Watkins J. 2003. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 17:24–38.
  • Mathews VV, Paul MV, Abhilash M, Manju A, Abhilash S, Nair RH. 2013. Myocardial toxicity of acute promyelocytic leukaemia drug-arsenic trioxide. Eur Rev Med Pharmacol Sci. 17:S34–S38.
  • Orrenius S, Zhivotovsky B, Nicotera P. 2003. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 4:552–565.
  • Prieto P, Pineda M, Aguilar M. 1999. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E. Anal Biochem. 269:337–341.
  • Quiles JL, Huertas JR, Battino M, Mataix J, Ramírez-Tortosa MC. 2002. Antioxidant nutrients and adriamycin toxicity. Toxicology. 180:79–95.
  • Raghu KG, Yadav GK, Singh R, Prathapan A, Sharma S, Bhadauria S. 2009. Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug. J Environ Pathol Toxicol Oncol. 28:241.
  • Salonen JT, Nyyssönen K, Salonen R, Lakka HM, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Lakka TA, Rissanen T, Leskinen L, et al. 2000. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3‐year progression of carotid atherosclerosis. J Intern Med. 248:377–386.
  • Shen ZY, Shen WY, Chen MH, Shen J, Cai WJ, Zeng Y. 2002. Mitochondria, calcium and nitric oxide in the apoptotic pathway of esophageal carcinoma cells induced by As2O3. Int J Mol Med. 9:385–390.
  • Taguchi K, Motohashi H, Yamamoto M. 2011. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution. Genes Cells. 16:123–140.
  • Ting CM, Lee YM, Wong CKC, Wong AS, Lung HL, Lung ML, Lo KW, Wong RNS, Mak NK. 2010. 2-Methoxyestradiol induces endoreduplication through the induction of mitochondrial oxidative stress and the activation of MAPK signaling pathways. Biochem Pharmacol. 79:825–841.
  • Unnikrishnan D, Dutcher JP, Varshneya N, Lucariello R, Api M, Garl S, Wiernik PH, Chiaramida S. 2001. Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood. 97:1514–1516.
  • Varghese MV, Abhilash M, Paul MVS, Alex M, Nair RH. 2017. Omega-3 fatty acid protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Cardiovasc Toxicol. 17:1–11.
  • Villeneuve NF, Lau A, Zhang DD. 2010. Regulation of the Nrf2–Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid Redox Signal. 13:1699–1712.
  • Wang Y, Zhao X, Gao X, Nie X, Yang Y, Fan X. 2011. Development of fluorescence imaging-based assay for screening cardioprotective compounds from medicinal plants. Anal Chim Acta. 702:87–94.
  • Ye Z, Song H. 2008. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 15:26–34.
  • Zhao X, Feng T, Chen H, Shan H, Zhang Y, Lu Y, Yang B. 2008. Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity. Basic Clin Pharmacol Toxicol. 102:419–425.
  • Zhou S, Sun W, Zhang Z, Zheng Y. 2014. The role of Nrf2-mediated pathway in cardiac remodeling and heart failure. Oxid Med Cell Longev. 2014:1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.